Innoviva (NASDAQ: INVA) reported Q3 EPS of $0.98, $0.71 better than the analyst estimate of $0.27. Revenue for the quarter came in at $67.26 million versus the consensus estimate of $75.66 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.